Clinical Trial Update: Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) [Phase 3]

View source ↗

Summary

Phase 3 Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) has completed; the update describes a trial evaluating strategies to prevent sudden death in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiovascular Diseases
• Heart Failure
• Sudden Cardiac Death

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED